Lung cancer || Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)




Last Updated: Sep 01, 2016

• Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis.
  Zhang Shumeng, et al. Oncotarget 2016 8
• Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-analysis.
  Chen Li-Shiun, et al. EBioMedicine 2016 8
• [DNA damage associated genetic variants contribute to lung cancer susceptibility in a Han Chinese population].
  Li Z H, et al. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2016 8 (8) 721-7
• Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study).
  Takahama Takayuki, et al. Oncotarget 2016 8
• Leptomeningeal metastases in non-small cell lung cancer patients with EGFR mutations.
  Li Yang-Si, et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 7
• Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
  Li Zhao, et al. Oncotarget 2016 8
• Targeted Therapies for Lung Cancer.
  Stinchcombe Thomas E, et al. Cancer treatment and research 2016 0 165-82
• The impact of epidermal growth factor receptor mutations on patterns of disease recurrence after chemoradiotherapy for locally advanced non-small cell lung cancer: a literature review and pooled analysis.
  Ochiai Satoru, et al. Journal of radiation research 2016 8
• [Genetic variation in DNA repair gene RAD52 is associated with the response to platinum-based chemotherapy in SCLC patients].
  Li H M, et al. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2016 7 (7) 504-9
• Epidermal growth factor receptor and v-Ki-ras2 Kirsten rat sarcoma viral oncogen homologue-specific amino acid substitutions are associated with different histopathological prognostic factors in resected non-small-cell lung cancer.
  Seitlinger Joseph, et al. Interactive cardiovascular and thoracic surgery 2016 8
• Allele-specific PCR method for identification of EGFR mutations in non-small cell lung cancer: formalin-fixed paraffin-embedded tissue versus fresh tissue.
  Suciu Bogdan Andrei, et al. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2016 0 (2) 495-500
• Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.
  Pan Szu-Hua, et al. Asia-Pacific journal of clinical oncology 2016 8
• Glutathione S-transferase pi polymorphism contributes to the treatment outcomes of advanced non-small cell lung cancer patients in a Chinese population.
  Chen J B, et al. Genetics and molecular research : GMR 2016 0 (3)
• Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
  Ben Amor Amira, et al. PloS one 2016 0 (8) e0161210
• PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer.
  Han Ji-Youn, et al. BMC cancer 2016 0 627

• CDC Information (2)
• CDC-Authored Pub (8)

• Human (30)
• Pathogen (0)

• Human (3905)
• Pathogen (0)

• Human (63)
• Pathogen (0)

• Guidelines (8)
• Tier Table (4)
• Synthesis (11)

• Huamn (4)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB